Tuesday, August 22, 2017 8:20:27 PM
The hearing in this proceeding was held on August 9, 2017. I ORDER the following post-hearing schedule:
1. By August 25, 2017, the parties shall jointly file paper copies of their exhibits, both admitted and those offered but not admitted, with the Commission’s Office of the Secretary. See 17 C.F.R. §§ 201.350(a)(3), (b), .351(c).
2. Also by August 25, 2017, the parties shall file a joint list of admitted exhibits and exhibits that were offered but not admitted. See 17 C.F.R. § 201.351(b). This list should specify the exhibit number; description of the exhibit; Bates-stamp numbers, if any; and page(s) in the hearing transcript on which the exhibit was offered and admitted, if applicable.
3. By September 8, 2017, the parties shall file proposed transcript corrections, if any, whether by motion or stipulation. See 17 C.F.R. § 201.302(c). Any objections to proposed transcript corrections are due by September 15, 2017.
4. By September 29, 2017, the parties shall simultaneously file their opening post-hearing briefs. See 17 C.F.R. § 201.340(a), (b). The parties are not required to submit separate filings with proposed, enumerated findings of fact. But the parties’ factual assertions should be accompanied by citations to the record.
5. By October 20, 2017, the parties shall file their responsive post- hearing briefs and counterstatements to proposed findings of fact, if any. The parties should provide electronic courtesy copies of all of these post- hearing submissions. Electronic copies of the exhibits should be provided in a format, such as PDF, that is paginated identically to the paper copies submitted to the Secretary. In addition to being filed with the Secretary’s office, the parties’ exhibit list, proposed transcript corrections and objections, and post-hearing briefs should be emailed to alj@sec.gov, in both PDF text- searchable format and MS Word format. _______________________________ Jason S. Patil Administrative Law Judge
Recent DBMM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:32:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 09:31:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 09:15:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM